CTRI/2022/05/042379
Not yet recruiting
未知
Influence of surfactant administration on neonatal outcomes in a tertiary care neonatal unit in South India
Riya Asokan0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: P073- Preterm [premature] newborn [other]
- Sponsor
- Riya Asokan
- Status
- Not yet recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •All inborn neonates with respiratory distress born between 23\-34 weeks.
Exclusion Criteria
- •Newborns \>34 weeks gestation at birth
- •All out born babies
- •Infants who received surfactant for indications other than RDS (Eg; Pulmonary hemorrhage, Meconium aspiration)
- •Infants with fatal congenital anomalies
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Impact of Surfactant's Availability on NewbornsLung DiseasesRespiratory Distress SyndromeNCT00005432National Heart, Lung, and Blood Institute (NHLBI)
Completed
Not Applicable
The Effect of Surfactant Dose on Outcomes in Preterm Infants With RDSRespiratory Distress SyndromeBronchopulmonary DysplasiaNCT03808402Chiesi UK2,973
Recruiting
Phase 3
The effect of surfactant on clinical outcome of patients with COVID-19Mortality of Patients from COVID-19.COVID-19U07.1IRCT20091201002804N12Shahid Beheshti University of Medical Sciences60
Completed
Not Applicable
MISA to NRDS:a Multicenter Study in ChinaBronchopulmonary DysplasiaPatent Ductus ArteriosusIntraventricular HemorrhageNecrotizing EnterocolitisPeriventricular LeukomalaciaNCT04077333Peking University Third Hospital237
Active, not recruiting
Phase 1
Effects of late surfactant treatment delivered after a recruitment maneuver on respiratory outcomes in extremely low gestational age newborns: a randomized controlled trial – LATE-REC-SURF Trial.Preterm infants still requiring mechanical ventilation at 7-10 days of life.MedDRA version: 20.0Level: LLTClassification code 10076729Term: Very preterm infantSystem Organ Class: 100000004868Therapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]EUCTR2019-004720-38-ITFONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS UNIVERSITA' CATTOLICA DEL SACRO CUORE20